158 related articles for article (PubMed ID: 31008996)
1. Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia Patients.
Muller IB; Lin M; Struys EA; Heydari P; Hebing RCF; Nurmohamed MT; van der Laken C; Lems WF; Cloos J; Jansen G; de Jonge R
Ther Drug Monit; 2019 Oct; 41(5):598-606. PubMed ID: 31008996
[TBL] [Abstract][Full Text] [Related]
2. Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
Rots MG; Pieters R; Peters GJ; Noordhuis P; van Zantwijk CH; Kaspers GJ; Hählen K; Creutzig U; Veerman AJ; Jansen G
Blood; 1999 Mar; 93(5):1677-83. PubMed ID: 10029597
[TBL] [Abstract][Full Text] [Related]
3. Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance.
Wojtuszkiewicz A; Raz S; Stark M; Assaraf YG; Jansen G; Peters GJ; Sonneveld E; Kaspers GJ; Cloos J
Int J Cancer; 2016 Apr; 138(7):1645-56. PubMed ID: 26547381
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR
Leukemia; 1993 Dec; 7(12):1996-2003. PubMed ID: 8255099
[TBL] [Abstract][Full Text] [Related]
5. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
6. Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis.
Muller IB; Lin M; Lems WF; Ter Wee MM; Wojtuszkiewicz A; Nurmohamed MT; Cloos J; Assaraf YG; Jansen G; de Jonge R
Rheumatology (Oxford); 2021 Mar; 60(3):1273-1281. PubMed ID: 32940699
[TBL] [Abstract][Full Text] [Related]
7. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.
Stark M; Wichman C; Avivi I; Assaraf YG
Blood; 2009 Apr; 113(18):4362-9. PubMed ID: 19131550
[TBL] [Abstract][Full Text] [Related]
8. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia.
Barredo JC; Synold TW; Laver J; Relling MV; Pui CH; Priest DG; Evans WE
Blood; 1994 Jul; 84(2):564-9. PubMed ID: 7517720
[TBL] [Abstract][Full Text] [Related]
9. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines.
McCloskey DE; McGuire JJ; Russell CA; Rowan BG; Bertino JR; Pizzorno G; Mini E
J Biol Chem; 1991 Apr; 266(10):6181-7. PubMed ID: 2007575
[TBL] [Abstract][Full Text] [Related]
10. [The mbr-FPGS efficient expression plasmid enhances the sensitivity of Jurkat cells to methotrexate].
Hu WJ; Sun YJ
Yi Chuan; 2012 Jun; 34(6):705-10. PubMed ID: 22698741
[TBL] [Abstract][Full Text] [Related]
11. Glutamic Acid Increased Methotrexate Polyglutamation and Cytotoxicity in a CCRF-SB Acute Lymphoblastic Leukemia Cell Line.
Mendoza-Santiago A; Becerra E; Garay E; Bah M; Berumen-Segura L; Escobar-Cabrera J; Hernández-Pérez A; García-Alcocer G
Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31779260
[No Abstract] [Full Text] [Related]
12. Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity.
Galpin AJ; Schuetz JD; Masson E; Yanishevski Y; Synold TW; Barredo JC; Pui CH; Relling MV; Evans WE
Mol Pharmacol; 1997 Jul; 52(1):155-63. PubMed ID: 9224825
[TBL] [Abstract][Full Text] [Related]
13. Activation of mammalian folylpolyglutamate synthetase by sodium bicarbonate.
Bolanowska WE; Russell CA; McGuire JJ
Arch Biochem Biophys; 1990 Sep; 281(2):198-203. PubMed ID: 2168155
[TBL] [Abstract][Full Text] [Related]
14. Analysis of folylpoly-gamma-glutamate synthetase gene expression in human B-precursor ALL and T-lineage ALL cells.
Leclerc GJ; Leclerc GM; Kinser TT; Barredo JC
BMC Cancer; 2006 May; 6():132. PubMed ID: 16707018
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation.
Gorlick R; Cole P; Banerjee D; Longo G; Li WW; Hochhauser D; Bertino JR
Adv Exp Med Biol; 1999; 457():543-50. PubMed ID: 10500832
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients.
Lenz HJ; Danenberg K; Schnieders B; Goeker E; Peters GJ; Garrow T; Shane B; Bertino JR; Danenberg PV
Oncol Res; 1994; 6(7):329-35. PubMed ID: 7865908
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
[TBL] [Abstract][Full Text] [Related]
18. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
19. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
20. Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells.
Panetta JC; Sparreboom A; Pui CH; Relling MV; Evans WE
PLoS Comput Biol; 2010 Dec; 6(12):e1001019. PubMed ID: 21152005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
